Please use this identifier to cite or link to this item:
Title: Genetic test for the channelopaties: useful or less than useful for patients? (part 2.)
Authors: Romano, Rosalba
Parisi, Valentina
Pastore, Fabio
Riccio, A.
Petraglia, Laura
Allocca, Elena
Leosco, Dario
Keywords: Channelopaties
Long QT syndrome
Short QT syndrome
Catecholaminergic polymorphic ventricular tachycardia
Brugada syndrome
Genetic testing
Issue Date: 2013
Citation: Romano R, Parisi V, Pastore F, et al. Genetic test for the channelopaties: useful or less than useful for patients? (part 2.). Translational Medicine @ UniSa 2013;6(6):35-40
Abstract: The advanced knowledge about genetic diseases and their mutations has widened the possibility to have a more precise and definitive diagnosis in many patients, but the use of genetic testing is still controversial. Actually, many cardiomyopathies show the availability of genetic testing. The clinical utility of this testing has been widely debated, but it is evident that the use of genetics must be put in a more organic diagnostic pathway that includes the evaluation of risks and benefits for the patient and his relatives, as well as the costs of the procedure. This review aims to clarify the role of genetic in clinics regarding Channelopaties, less frequent but equally important than other Cardiomyopathies because patients can often be asymptomatic until the first fatal manifestation.
ISSN: 2239-9747
Appears in Collections:Translational Medicine @ UniSa. Vol.6(may.-aug.2013)

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.